$213.24-2.43 (-1.13%)
STERIS plc provides infection prevention products and services worldwide.
STERIS plc in the Healthcare sector is trading at $213.24 with a market capitalization of $20.2B. Wall Street consensus targets $256.86 (7 analysts), implying a +20.5% move over the next 12 months. The stock is currently 21% below its 52-week high of $269.44, remaining 9.9% below its 200-day moving average. On fundamentals, Piotroski 9/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.59B↑ | $1.50B↑ | $1.46B↑ | $1.39B↓ | $1.48B |
| Gross Profit | $697.10M↑ | $655.50M↑ | $645.90M↑ | $628.00M↓ | $641.21M |
| Operating Income | $316.50M↑ | $273.70M↑ | $268.00M↑ | $247.80M↓ | $279.62M |
| Net Income | $220.20M↑ | $192.80M↑ | $191.90M↑ | $177.40M↑ | $145.67M |
STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assuran...
CVRx (CVRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
STERIS’s stock price has taken a beating over the past six months, shedding 20.4% of its value and falling to $202.39 per share. This might have investors contemplating their next move.
While STERIS has underperformed relative to the Dow over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.
STERIS (STE) is back in focus after reporting fourth quarter fiscal 2026 results, with adjusted earnings per share of US$2.83 missing consensus by 0.9% and revenue growth of 7.3% coming in slightly under estimates. See our latest analysis for STERIS. At a share price of US$207.22, STERIS has seen its 1-day, 7-day, 30-day and 90-day share price returns all move lower, and the year to date share price return is down 17.1%, while the 1-year total shareholder return is down 13.6%. This is despite...
Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.